BioNTech
BNTX
BNTX
287 hedge funds and large institutions have $5.9B invested in BioNTech in 2022 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 105 increasing their positions, 80 reducing their positions, and 113 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
35% less capital invested
Capital invested by funds: $9.07B → $5.9B (-$3.17B)
40% less call options, than puts
Call options by funds: $572M | Put options by funds: $946M
52% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 113
Holders
287
Holding in Top 10
6
Calls
$572M
Puts
$946M
Top Buyers
| 1 | +$323M | |
| 2 | +$155M | |
| 3 | +$58M | |
| 4 |
BlackRock
New York
|
+$55.6M |
| 5 |
D.E. Shaw & Co
New York
|
+$53.9M |
Top Sellers
| 1 | -$494M | |
| 2 | -$194M | |
| 3 | -$156M | |
| 4 |
Coatue Management
New York
|
-$107M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
-$88.6M |